SPECTRALYS BIOTECH: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SPECTRALYS BIOTECH
Largest movements
- Intangible fixed assets +€63,822
up €63,822 (+95.0%), from €67,199 to €131,021
- Cash +€45,029
up €45,029 (+44.3%), from €101,733 to €146,762
mainly Other debts (+€64,150) and Net result for the year (+€58,165)
- Receivables within one year +€31,193
up €31,193 (+139%), from €22,372 to €53,565
of which Other amounts receivable: +€22,422
- Other debts +€64,150
up €64,150 (+219%), from €29,354 to €93,504
- Investment grants +€51,088
up €51,088 (+95.0%), from €53,755 to €104,843
- Trade debts +€8,988
up €8,988 (+162%), from €5,556 to €14,544
- Profit (loss) carried forward +€8,165
up €8,165 (+4.5%), from €179,540 to €187,705
- Tax, wage and social debts +€7,123
up €7,123 (+43.2%), from €16,485 to €23,608
of which Taxes: +€4,699
- Gross operating margin +€40,141
up €40,141 (+38.8%), from €103,548 to €143,689
- Taxes +€7,688
up €7,688 (+168%), from €4,564 to €12,252
- Staff costs +€3,238
up €3,238 (+4.7%), from €68,700 to €71,938
- Depreciation -€1,746
down €1,746 (-12.1%), from €14,371 to €12,625
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €305,222 | €444,695 | +€139,473 | +45.7% |
| Fixed assets | 21/28 | €67,259 | €131,081 | +€63,822 | +94.9% |
| Intangible fixed assets | 21 | €67,199 | €131,021 | +€63,822 | +95.0% |
| Financial fixed assets | 28 | €60 | €60 | = | 0.0% |
| Current assets | 29/58 | €237,962 | €313,613 | +€75,651 | +31.8% |
| Amounts receivable within one year | 40/41 | €22,372 | €53,565 | +€31,193 | +139% |
| Trade receivables | 40 | €15,429 | €24,200 | +€8,771 | +56.8% |
| Other amounts receivable | 41 | €6,943 | €29,365 | +€22,422 | +323% |
| Current investments | 50/53 | €111,428 | €106,983 | -€4,444 | -4.0% |
| Cash at bank and in hand | 54/58 | €101,733 | €146,762 | +€45,029 | +44.3% |
| Deferred charges and accrued income | 490/1 | €2,430 | €6,303 | +€3,873 | +159% |
| Total equity and liabilities | 10/49 | €305,222 | €444,695 | +€139,473 | +45.7% |
| Equity | 10/15 | €253,755 | €313,008 | +€59,252 | +23.4% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €179,540 | €187,705 | +€8,165 | +4.5% |
| Investment grants | 15 | €53,755 | €104,843 | +€51,088 | +95.0% |
| Amounts payable | 17/49 | €51,466 | €131,687 | +€80,221 | +156% |
| Amounts payable within one year | 42/48 | €51,395 | €131,656 | +€80,261 | +156% |
| Trade debts | 44 | €5,556 | €14,544 | +€8,988 | +162% |
| Suppliers | 440/4 | €5,556 | €14,544 | +€8,988 | +162% |
| Taxes, remuneration and social security | 45 | €16,485 | €23,608 | +€7,123 | +43.2% |
| Taxes | 450/3 | €2,382 | €7,081 | +€4,699 | +197% |
| Remuneration and social security | 454/9 | €14,103 | €16,527 | +€2,424 | +17.2% |
| Other amounts payable | 47/48 | €29,354 | €93,504 | +€64,150 | +219% |
| Accrued charges and deferred income | 492/3 | €71 | €31 | -€40 | -56.3% |
| Remuneration, social security and pensions | 62 | €68,700 | €71,938 | +€3,238 | +4.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €14,371 | €12,625 | -€1,746 | -12.1% |
| Other operating charges | 640/8 | €643 | €1,417 | +€775 | +121% |
| Gross operating margin | 9900 | €103,548 | €143,689 | +€40,141 | +38.8% |
| Operating profit (loss) | 9901 | €19,834 | €57,709 | +€37,875 | +191% |
| Financial income | 75/76B | €14,061 | €12,832 | -€1,230 | -8.7% |
| Recurring financial income | 75 | €14,061 | €12,832 | -€1,230 | -8.7% |
| Financial charges | 65/66B | -€23 | €124 | +€147 | |
| Recurring financial charges | 65 | -€23 | €124 | +€147 | |
| Profit (loss) for the period before taxes | 9903 | €33,918 | €70,417 | +€36,498 | +108% |
| Income taxes | 67/77 | €4,564 | €12,252 | +€7,688 | +168% |
| Profit (loss) for the period | 9904 | €29,354 | €58,165 | +€28,810 | +98.1% |
| Profit (loss) for the period to be appropriated | 9905 | €29,354 | €58,165 | +€28,810 | +98.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.